Albavera-Hernandez C., Rodriguez JM, Idrovo AJSafety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Clin Rehabil2009; 23: 394-407.
2.
Idrovo AJ, Albavera-Hernandez C., Rodriguez JMLetter to the editor on ‘Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials’. Clin Rehabil2009; 23: 862-63.
3.
Graham HK, Boyd R., Carlin JB et al. Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and ‘hips at risk’? A randomized, controlled trial. J Bone Joint Surg Am2008 ; 90: 23-33.
4.
Russo RN, Crotty M., Miller MD, Murchland S., Flett P., Haan E.Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial. Pediatrics2007 ; 119: e1149-e1158.
5.
Lowe K., Novak I., Cusick A.Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy. Dev Med Child Neurol2007; 49: 823-29.
6.
Lowe K., Novak I., Cusick A.Low-dose/high concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy. Dev Med Child Neurol2006; 48: 170-5.
7.
Baker R., Jasinski M., Maciag-Tymecka I. et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol2002; 44: 666-75.
8.
Ubhi T., Bhakta BB, Ives HL, Allgar V., Roussounis SHRandomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child2000; 83: 481-87.
9.
Moore AP, de-Hall RA, Smith CT et al. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy. Neurology2008 ; 71: 122-28.
10.
Albavera-Hernández C., Rodríguez JM, Idrovo AJSafety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Clin Rehabil2009; 23: 394-407.
11.
Brin MF, Pogoda JN, Boodhoo T., Bowen B.Botulinum toxin type A treatment does not increase the risk of seizures in juvenile cerebral palsy (Reply to Albavera-Hernandez et al. , Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials) . Clin Rehabil (in press).
